Jefferies Downgrades Rallybio to Hold, Lowers Price Target to $1.5
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Eun Yang downgraded Rallybio (NASDAQ:RLYB) from Buy to Hold and reduced the price target from $7 to $1.5, indicating a more cautious outlook on the company's stock.
February 07, 2024 | 12:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Jefferies analyst Eun Yang downgraded Rallybio from Buy to Hold and lowered the price target from $7 to $1.5.
The downgrade from Buy to Hold by a prominent analyst at Jefferies, coupled with a significant reduction in the price target, suggests a bearish outlook on Rallybio's stock. This could lead to a decrease in investor confidence and potentially result in a short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100